Fed. Circ. Unsure Vanda's Sleep Med Hetlioz Is Patentable
A Federal Circuit panel seemed wary Tuesday of Vanda Pharmaceuticals' attempt to overturn a Delaware federal judge's decision invalidating four patents related to its sleep disorder treatment drug Hetlioz, questioning whether...To view the full article, register now.
Already a subscriber? Click here to view full article